BIOA BioAge Labs shares fall 637 percent post Q4 2025 earnings despite narrower than expected per share loss SJM The JM reports 67 percent year over year Q1 2001 revenue growth alongside a narrow earnings miss against consensus estimates How Soligenix SNGX pricing offsets input costs Q4 2025 EPS Tops Views US USBQ Stock Investment Case Evaluation USBQ Earnings US Series L preferred has no published financial results XPEL XPEL Stock Why Barrier to Entry Slight Uptick 20260420 ONTO Q1 2026 Earnings EPS Misses Estimates by 163 Amid Unreported Revenue CCSI Q1 2026 Earnings Strong EPS Beat Amidst Cautious Outlook FORA Q1 2026 Earnings Steep EPS Miss Overshadows Quarter as Revenue Remains Undisclosed VICR Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Not Disclosed SGU Q1 2026 Earnings Strong Earnings Performance Amid Seasonal Peak Canadian National Railway CNI Q1 2026 Earnings EPS Beats Estimates in a Challenging Freight Environment